A vaccine is a biological preparation that improves immunity to a particular disease. A vaccine typically contains an agent that resembles a disease-causing microorganism, and is often made from weakened or killed forms of the microbe, its toxins or one of its surface proteins. The agent stimulates the body's immune system to recognize the agent as foreign, destroy it, and "remember" it, so that the immune system can more easily recognize and destroy any of these microorganisms that it later encounters.
Travelers are at increased risk for several infections, including familiar infections such as measles that are widely distributed but more common in developing countries. Travelers Vaccines can markedly decrease the risk for many of these infections and are an important part of pretravel preparation.
In this report, the travelers vaccines mainly covers vaccine for hepatitis A, hepatitis B, rabies, typhoid fever, yellow fever, Japanese encephalitis, meningococcal meningitis, cholera, etc.
This report contains market size and forecasts of Travelers Vaccines in India, highlights the following information:
Sales of Travelers Vaccines in India: Value 2019 VS 2023 VS 2030, ($ millions)
Sales of Travelers Vaccines in India: Volume 2019 VS 2023 VS 2030, (K Doses)
Sales of Travelers Vaccines in India: Revenue Market Share by Company, 2019-2024
Sales of Travelers Vaccines in India: Volume Market Share by Company, 2019-2024
India is now the world’s most populous country. According to IMF (its July update to its World Economic Outlook), India’s GDP growth is projected at 6.1% in 2023, powered by domestic investment. First and foremost, the key factor in India's rapid economic growth is the huge supply and demand from a large population base. Demand and supply sides working in both directions to support India's economic stability.
India is a market full of opportunities, and the demand for Travelers Vaccines will continue to grow rapidly in the future.
The global Travelers Vaccines market size was valued at 3363.3 million in 2023 and is forecast to a readjusted size of US$ 6111.4 million by 2030, with a CAGR of 8.8% during the forecast period 2024-2030.While the India Travelers Vaccines market was valued at US$ million in 2023 and is projected to reach US$ million by 2030, at a CAGR of % during the forecast period. India will account for % percent of Travelers Vaccines's global value in 2030, from % in 2023.
Our research team has surveyed the Travelers Vaccines manufacturers, suppliers, distributors, and industry experts on this industry, involving the sales, Value, demand, price change, product matrix, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
India Travelers Vaccines Market, By Type, 2019-2024, 2025-2030 ($ Millions) & (K Doses)
India Travelers Vaccines Market Segment Percentages, By Type, 2023 (%)
Japanese Encephalitis Vaccine
India Travelers Vaccines Market, By End Users, 2019-2024, 2025-2030 ($ Millions) & (K Doses)
India Travelers Vaccines Market Segment Percentages, By End Users, 2023 (%)
The report also provides analysis of leading market participants including:
Key companies Travelers Vaccines revenues in India market, 2019-2024 (Estimated), ($ millions)
Key companies Travelers Vaccines sales in India market, 2019-2024 (Estimated), (K Doses)
Further, the report presents profiles of competitors in the market, key players include: